Apr 122018

I am quoted in the May 2018 issue of Kiplinger’s Personal Finance – “What Would Warren Do?”

“Still, at its current price, Teva would not be the bargain for you that it was for Buffett. Teva’s average price was roughly $14.50 a share during the fourth quarter, says David Kass, University of Maryland finance professor and longtime Buffett watcher. If you bought now, you’d pay more than 30% more than Buffett did.” 


 Posted by at 8:47 pm

Sorry, the comment form is closed at this time.